1) Cyclosporin H
环孢菌素H
1.
Cyclosporin H produced by Fusarium solani: Purification and structural identification;
茄病镰刀菌产生的环孢菌素H的研究——分离纯化和结构鉴别
2.
Recent studies have showed that cyclosporin H(CsH) displays more potent inhibition for human FPR(Formyl-peptid receptor) than most of other antagonists.
环孢菌素H(CsH)对甲酰肽受体(FPR)功能的拮抗作用强于其他许多甲酰肽受体拮抗剂,在逆转肿瘤多药耐药、抗寄生虫以及抗病毒等方面也有一定的作用。
2) cyclosporine A
环孢菌素A
1.
Preparation of self-microemulsifying semi-solid matrix hard capsules of cyclosporine A;
环孢菌素A自乳化半固体骨架胶囊的制备
2.
In Vitro study of the effect of cyclosporine A,tetrandrine and their combination on the reversion of multidrug resistance in leukemia cell line;
环孢菌素A、汉防己甲素及两者联合逆转K562/A02细胞的多药耐药
3.
General physiologically pharmcokinetics model of cyclosporine A;
环孢菌素A的生理药物动力学模型
3) cyclosporine
[英][,saikləu'spɔ:ri:n] [美][,saɪklə'spɔrin, -ɪn, -'spor-]
环孢菌素
1.
Comparison between cyclosporine and glucocorticoid in treatment of oral lichen planus:a systematic review
比较环孢菌素与糖皮质激素治疗口腔扁平苔藓的系统评价
2.
Diazoxide and Cyclosporine A inhibits cultured primitive rat basal forebrain cholinergic neuron apoptosis induced by Aβ_(1-42)
二氮嗪、环孢菌素A拮抗Aβ_(1-42)致胆碱能神经元凋亡的研究
3.
OBJECTIVE To construct a population pharmacokinetic model for cyclosporine, which was constructed by NONMEM, and to adjust administration individually.
目的以环孢菌素(CSA)为模型药物,在NONMEM程序构建的群体药动学模型的基础上,通过EXCEL实现个体化给药。
4) cyclosporin A
环孢菌素A
1.
Clinical observation of cyclosporin A in treatment of severe ulcerative colitis;
环孢菌素A治疗重度溃疡性结肠炎的临床观察
2.
Effects of combination of Genistein with Cyclosporin A on immune response of mouse lymphocytes in vitro;
染料木黄酮与环孢菌素A联合用药对小鼠淋巴细胞体外免疫应答的影响
3.
Effect of cyclosporin A on sorcin gene expression and clinical effect in multiple myeloma patients;
环孢菌素A对多发性骨髓瘤患者Sorcin基因表达和临床疗效的影响
5) cyclosporin
[,saikləu'spɔ:rin]
环孢菌素
1.
Investigation of Drug Resistance of Monilia to Fluconazole and 5-fluocytosine and the Synergistic Effect of Fluconazole and Cyclosporin in Vitro;
35株念珠菌药敏分析及氟康唑和环孢菌素的体外协同作用
2.
Objective To investigate the clinical effect of cyclosporin A(CsA) as a reversal agent associated with classical chemotheraphy to reverse multidrug resistance(MDR) in refractory acute leukemia(RAL).
目的:探讨环孢菌素A(CsA)作为耐药逆转剂联合化疗逆转难治性急性白血病(RAL)多药耐药(MDR)的临床疗效。
3.
Objective To observe the therapeutic effect of TCM syndrome-typing based therapy(TCM-STBT)combined with cyclosporin on myelodysplastic syndrome(MDS)and investigate the correlation of efficacy with TCM syndrome type and MDS type.
目的观察中医分型论治联合环孢菌素治疗骨髓增生异常综合征的临床疗效及中医不同证型与西医分型在疗效方面的相关性。
6) cyclosporine A
环孢菌素
1.
The purpose of study was to evaluate the effect of stopping use of cyclosporine A(CsA)in reversion of donor chimeras of chronic myeloid leukemia(CML)patients relapsed after transplantation.
本研究探讨慢性髓系白血病患者移植后复发时停用环孢菌素A(CsA)对逆转供者型嵌合体的作用。
2.
The present study was to investigate the mRNA, protein expression and the activity of calci-neurin in the hypertrophic heart, and to determine the effect of calcineurin inhibitor —— cyclosporine A(CsA) on the regression of cardiac hypertrophy in renovascular hypertensive rats.
本文观察了钙调神经磷酸酶(calcineurin,CaN)在肾血管性高血压大鼠肥厚心肌中的表达和活性以及CaN抑制剂——环孢菌素A(cyclosporine A,CsA)对逆转心肌肥厚的影响。
补充资料：环孢菌素
分子式：C62H111N11O12
分子量：1202.63
CAS号：59865-13-3
性质：白色或类白色结晶性粉末，无臭无味。
制备方法：暂无
用途：治疗白血病、癌、肾移植、结核病等。
分子量：1202.63
CAS号：59865-13-3
性质：白色或类白色结晶性粉末，无臭无味。
制备方法：暂无
用途：治疗白血病、癌、肾移植、结核病等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条